Trial Profile

Prospective Study of Induction Medications Used in the Rapid Sequence Intubation of Trauma Patients and a Comparison of Effects on Outcomes

Status: Not yet recruiting

Phase of Trial: Phase IV

Latest Information Update: 08 Mar 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Etomidate (Primary) ; Ketamine (Primary) ; Propofol (Primary)
Indications Sedation
Focus Adverse reactions
Acronyms ProTIM

Most Recent Events

03 Mar 2024 Planned End Date changed from 30 Jul 2026 to 30 Jul 2028.
03 Mar 2024 Planned primary completion date changed from 30 Apr 2026 to 30 Apr 2028.
03 Mar 2024 Planned initiation date changed from 1 Jan 2024 to 1 Jan 2026.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com